Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis
Autor: | Macky M. Done, Riejanne Stienstra, Tjip S. van der Werf, Wiel C M de Lange, Wud Al-Kailany, Onno W. Akkerman, Gonda J. de Jonge, Johanneke Kleinnijenhuis |
---|---|
Přispěvatelé: | Microbes in Health and Disease (MHD) |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Microbiology (medical) Adult Male medicine.medical_specialty Tuberculosis 030106 microbiology Anti-Inflammatory Agents Inflammation Case Report ANTITUBERCULOSIS THERAPY law.invention 03 medical and health sciences 0302 clinical medicine Paradoxical reaction Randomized controlled trial Pulmonary tuberculosis law Adrenal Cortex Hormones INFLIXIMAB medicine Humans Corticosteroids SIRS 030212 general & internal medicine Intensive care medicine Tuberculosis Pulmonary business.industry General Medicine Middle Aged medicine.disease Pathophysiology Infliximab Morocco Infectious Diseases Prednisolone France Poland medicine.symptom business medicine.drug |
Zdroj: | Infection Infection, 48. Urban und Vogel GmbH |
ISSN: | 0300-8126 |
Popis: | Background Paradoxical reaction after the initiation of tuberculosis treatment is defined as increased inflammation following effective antimycobacterial treatment. This is a phenomenon that can severely complicate a patient’s recovery, potentially leading to further morbidity and residual deficits. Paradoxical reaction remains poorly understood regarding its pathophysiology and management. Only a limited number of reports look critically at the available therapeutic options, with evidence of the efficacy of prednisolone therapy being primarily limited to extrapulmonary PR only. Case We describe two HIV negative patients who were admitted to our department with pulmonary tuberculosis, presenting with inflammatory patterns attributable to PR and their response to adjunctive steroid therapy. Discussion and Conclusions The presented cases further highlight the need for immunological studies and randomized trials for corticosteroid therapy are needed to better understand this phenomenon as well as provide an evidence-base for anti-inflammatory treatment. Furthermore, by means of this case series, we are also able to highlight the potential variability in the symptomatology of the lesser known PR phenomenon, in which we observed a hypotensive shock-like syndrome not previously described in literature. |
Databáze: | OpenAIRE |
Externí odkaz: |